A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. (IRIS)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Cancer Research UK
Information provided by (Responsible Party):
Kelly Mousa, Imperial College London
ClinicalTrials.gov Identifier:
NCT01785992
First received: February 4, 2013
Last updated: March 10, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)